Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|15|3|196-204

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.15, Iss.3, 2015-05, pp. : 196-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotective Mechanisms Mediated by CDK5 Inhibition

By  

Current Pharmaceutical Design, Vol. 22, Iss. 5, 2016-02 ,pp. : 527-534

Bentham Science Publishers

Access to resources Recommend Favorite

11-Phenylundeca-5Z,9Z-dienoic Acid: Stereoselective Synthesis and Dual Topoisomerase I/IIα Inhibition

By  

Current Cancer Drug Targets, Vol. 15, Iss. 6, 2015-01 ,pp. : 504-510

Bentham Science Publishers

Access to resources Recommend Favorite

New Trends in Dual 5-LOX / COX Inhibition

By  

Current Medicinal Chemistry, Vol. 9, Iss. 9, 2002-05 ,pp. : 941-962

Bentham Science Publishers

Access to resources Recommend Favorite

Dual inhibition of MEK1/2 and EGFR synergistically induces caspase-3-dependent apoptosis in EGFR inhibitor-resistant lung cancer cells via BIM upregulation

By Song Ji-Young   Kim Choung-Soo   Lee Je-Hwan   Jang Se   Lee Sang-wook   Hwang Jung   Lim Chulsoo   Lee Gilnam   Seo Jeongbeob   Cho Suk   Choi Jene  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1458-1465

Springer Publishing Company

Access to resources Recommend Favorite

DH9, a novel PPARγ agonist suppresses the proliferation of ADPKD epithelial cells: An association with an inhibition of β-catenin signaling

By Liu Moyan   Fu Lili   Liu Chunyan   Xiong Xishan   Gao Xiang   Xiao Min   Cai Houan   Hu Huimin   Wang Xueqi   Mei Changlin  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 783-790

Springer Publishing Company

Access to resources Recommend Favorite